Safety, Tolerability, and Pharmacokinetic Characteristics of SSS11 in Patients With Gout and Hyperuricemia

NCT06629376 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

60

Enrollment

INDUSTRY

Sponsor class

Conditions

Gout
Hyperuricemia

Interventions

DRUG: Pegylated Recombinant Candida Utilis Uricase for Injection

Sponsor

Shenyang Sunshine Pharmaceutical Co., LTD.